HITLAB Welcomes Two New Board Members to Breakthrough Alliance

HITLAB is pleased to announce that Jonathan Hahn and Wayne Talleur of FFF Enterprises Inc. (FFF) have joined the Breakthrough Alliance (BTA) board. FFF Enterprises is the nation’s leading supplier of critical care plasma products (including albumin, immune globulin, and coagulation therapies), vaccines, and specialty pharmaceuticals.
The BTA is a digital health consortium of executive leaders from across life science, pharmaceutical, academic medical institutions, and healthcare providers, including New York City Economic Development Corporation, Merck Global Health Innovation, Johnson & Johnson,  Fund LLC, BDO, Atlas Venture, StartUp Health, CATALAIZE, Consummate Capital,  EdgeOne Medical, Esplanade Ventures, and Northwell Health, all committed to improving health outcomes and care delivery through verified emerging technologies. The board is chaired by Bill Taranto, the CEO of the Merck Global Innovation Fund.

The BTA board meets every quarter. All members have the benefits of:

• Setting priorities to guide the development of research studies for selected digital health technologies
• Receiving exclusive access to investment and partnership opportunities with the latest digital health tech under development

• Gaining insights into the future of digital health by seeing the results of the verified and risk-reduced studies.

“We are excited to expand our board with two new members who bring diverse expertise and insight into our work,” said Bill Taranto, CEO of Merck Global Health Innovation Fund and Chair of HITLAB BTA. “We have worked hard to ensure that our BTA board represents a variety of experts from the healthcare world, and our newest members, Mr. Hahn and Mr. Talleur, add to that diversity. We welcome them both to the team.”

“The mission of HITLAB’s BTA resonates deeply with our work at FFF Enterprises,” said Jonathan Hahn, Chief Information Officer. “FFF thrives on customer-driven innovation, and our overall goal is to unite biopharmaceutical manufacturers, GPOs, and hospital partners to contain costs and improve the availability of on-demand products. We look forward to working with HITLAB to further this goal.”

About HITLAB Breakthrough Alliance

HITLAB Breakthrough Alliance is an accelerator that helps early-stage startups conduct rapid pilot studies to test their products and move closer to market. Selected startups have their technologies tested in pilot studies with clinical partners and patients, gathering the data needed to accelerate their concepts. To source startups, Breakthrough holds open innovation competitions and networking events that bring together the digital health and investment ecosystem.

Breakthrough is membership-based and board members represent the best organizations in healthcare.